glp 1 tablet The FDA has approved the first pill version of GLP-1 drugs. Novo Nordisk says participants who took the Wegovy pill in clinical trials lost an average of 16.6% of their body weight Enthusiastic users have reported a noticeable decrease in hunger levels New GLP-1 drugs could suppress
Description
Clearly the brain/central nervous system effect of these drugs is gaining traction and considerable interest
people with type 2 diabetes and prior CVD)
Why Are Psychiatrists Interested
In an in vitro study, tirzepatide elicited a cAMP response in a human pancreatic -cell line that was significantly higher than that observed for either GLP-1 or GIP alone, indicating a synergistic or additive activation of signaling in pancreatic -cells by GIP and GLP-1 (63)
In addition to NAION, Wegovy patients may also face temporary blurred vision from fluctuating blood sugar levels, an increase in eye infections, and other vision issues
Ethics declarations Competing Interests Financial interests: Jaewang Lee and Hyun Jin Park are employed by Logsynk Ltd
